Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster
Case study – Gene expression profiling to understand and combat drug resistance
Case study – Gene expression profiling to understand and combat drug [...]
Proposed new combination treatment strategy for pediatric ALL published in Nature Communication
Oncolines contributes to a proposed new combination treatment strategy for pediatric [...]
Oncolines News Flash
First presentation of novel mitotic checkpoint inhibitor BAL0891 data at ESMO [...]
- Case study – Gene expression profiling to understand and combat drug resistancejanneke2022-04-14T11:52:58+02:00
- Combination matrix to determine Bliss independence synergy scoresNTRC Oncolines2021-11-17T16:21:49+01:00
- Case study – Pharmacological models to assess the role of tryptophan-metabolizing enzymes in cancerNTRC Oncolines2021-10-21T11:38:04+02:00
- Case study – Synergistic interaction of olaparib and cisplatinNTRC Oncolines2021-10-21T11:38:40+02:00
PREMIUM BENEFITS OF ONCOLINES PRECISION MEDICINE SERVICES: Cell-Based Assays, Drug Combinations, High-Throughput Screening
Integration of cancer biology and big data analysis
Identification of patient selection markers
Side-by-side comparison with known anti-cancer agents
Discovery of targeted and novel synergistic drug combinations
Science-driven technology platforms
Short turnaround times
